Ayabudge LLC - 25 May 2023 Form 4 Insider Report for Humacyte, Inc. (HUMA)

Role: 10%+ Owner
Signature: /s/ Ayabudge LLC by Dale A. Sander as Attorney-in-Fact
Issuer symbol: HUMA
Transactions as of: 25 May 2023
Net transactions value: -$7,218,750
Form type: 4
Filing time: 26 May 2023, 17:02:14 UTC
Previous filing: 19 Dec 2022
Next filing: 15 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HUMA	Common Stock	Sale	$7,218,750	-2,625,000	-15%	$2.75	15,365,736	25 May 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On May 25, 2023, the Reporting Person sold 2,625,000 shares of Common Stock. The transactions enabled Mr. Brady W. Dougan, a person controlling the Reporting Person, to pay down leverage while providing a mechanism for the institutional healthcare investor purchasers to acquire shares of the Issuer at a time that the Issuer was not conducting a financing transaction and was not making any additional shares available for purchase.

Content

On May 25, 2023, the Reporting Person sold 2,625,000 shares of Common Stock. The transactions enabled Mr. Brady W. Dougan, a person controlling the Reporting Person, to pay down leverage while providing a mechanism for the institutional healthcare investor purchasers to acquire shares of the Issuer at a time that the Issuer was not conducting a financing transaction and was not making any additional shares available for purchase.